LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
9/30/2025 | 6/30/2025 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | – | -$14 | -$28 |
| Dep. & Amort. | – | – | $0 | $0 |
| Deferred Tax | – | – | $0 | $0 |
| Stock-Based Comp. | – | – | $0 | $0 |
| Change in WC | – | – | -$10 | $10 |
| Other Non-Cash | – | – | $2 | $2 |
| Operating Cash Flow | – | – | -$22 | -$16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | – | -$0 | -$0 |
| Net Acquisitions | – | – | $0 | $0 |
| Inv. Purchases | – | – | $0 | -$4 |
| Inv. Sales/Matur. | – | – | $29 | $0 |
| Other Inv. Act. | – | – | $0 | $11 |
| Investing Cash Flow | – | – | $29 | $7 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | – | $0 | $0 |
| Stock Issued | – | – | $0 | $0 |
| Stock Repurch. | – | – | $0 | $0 |
| Dividends Paid | – | – | $0 | $0 |
| Other Fin. Act. | – | – | $0 | $0 |
| Financing Cash Flow | – | – | $0 | $0 |
| Forex Effect | – | – | -$7 | $0 |
| Net Chg. in Cash | – | – | $0 | -$9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | – | $0 | $18 |
| End Cash | – | – | $0 | $9 |
| Free Cash Flow | – | – | -$22 | -$16 |